Erratum
for
Saltz et al., J Clin Oncol 26 (12) 2013-2019.
Journal of Clinical Oncology, Vol 26, No 18 (June 20), 2008: pp. 3110
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.17.8616
ERRATUM
The April 20, 2008, article by Saltz et al entitled, "Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study" (J Clin Oncol 26:2013-2019, 2008) contained errors in the last two columns of Table 1.
The columns were labeled as FOLFOX-4 + Placebo and FOLFOX-4 + Bevacizumab, whereas they should have been labeled as XELOX + Placebo and XELOX + Bevacizumab, respectively. The no. of patients was given as 351 and 349, whereas it should have been 350 in both columns. The median age was given as 60, whereas it should have been 61 in both columns. The age range was given as 26-83 and 19-82, whereas it should have been 18-83 and 18-86, respectively.
The online version has been corrected in departure from the print.
|
